重塑多发性骨髓瘤治疗:最近的突破
Enrica Antonia Martino1, Santino Caserta1, Ernesto Vigna1
1Hematology Unit, Department of Onco-Hematology, AO of Cosenza, Cosenza, Italy.
Expert opinion on pharmacotherapy
|December 25, 2025
概括
双特异性抗体 (BsAbs) 和CAR-T细胞疗法的进展正在改变多发性骨髓瘤治疗,提供了深刻的反应. 个性化策略的目标是功能性治疗,同时应对毒性和复发等挑战.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- 多发性骨髓瘤 (MM) 的治疗环境正在迅速发展,新的基于免疫的策略正在迅速发展.
- 双特异性抗体 (BsAbs),仿真抗原受体T细胞 (CAR-T) 疗法和三特异性抗体 (TsAbs) 正在成为关键参与者.
研究的目的:
- 审查多发性骨髓瘤免疫疗法的当前状态和未来方向.
- 突出BsAbs和CAR-T治疗MM的有效性,挑战和持续的创新.
主要方法:
- 对MM中BsAbs (teclistamab,elranatamab,talquetamab) 和CAR-T疗法 (idecabtagene vicleucel,ciltacabtagene autoleucel) 的最新临床数据和文献的审查.
- 讨论包括T细胞枯竭,感染和后勤问题在内的挑战.
- 探索创新,如双重目标的CAR-T和异质平台.
主要成果:
- 现成的BsAbs在重度预治疗的MM患者中表现出显著的活性.
- 卡特-T疗法实现了高响应率和快速的最小残留疾病 (MRD) 消极性.
- 创新旨在提高耐用性,扩大使用范围,克服治疗局限性.
结论:
- 基于免疫的疗法正在重塑MM治疗范式,使得更深入,更持久的反应.
- 包括风险分层和MRD评估在内的个性化治疗策略至关重要.
- 目标是实现功能治疗,并改善MM患者的治疗结果.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
7.2K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
9.0K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
